NIH-funded research R21 grant

How immune responses change during acute Lyme disease due to altered antibody sugars

Official title: Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation

Funded at Drexel University · NIH-10908696 · Data updated 2026-11-12

This study is looking at how sugars on antibodies change when someone has acute Lyme disease, and it hopes to find patterns that could help doctors diagnose and treat the condition better.

More Lyme Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 16, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$187,033
NIH project number5R21AI178567-02
Project IDNIH-10908696 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently been diagnosed with acute Lyme disease.

Less likely to help

Patients who have chronic Lyme disease or those who are not currently experiencing acute symptoms may not benefit from this research.

What this research studies

This research investigates how the sugars attached to antibodies change during acute Lyme disease and how these changes affect the immune response. The study aims to identify specific patterns of glycosylation in immunoglobulins that occur in patients with acute Lyme disease, which may help in diagnosing the condition more reliably. By analyzing serum samples from patients, the researchers will explore how these glycosylation patterns influence inflammation and the overall immune response. This could lead to improved diagnostic methods and treatment strategies for Lyme disease.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and treatment options for patients with acute Lyme disease, potentially reducing long-term health complications.

How similar studies have gone: While this specific approach to studying glycosylation in Lyme disease is novel, similar research has shown that glycosylation patterns can significantly impact immune responses in other diseases.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Comunale, Mary Ann — Drexel University
  • Study coordinator: Comunale, Mary Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.